Results 61 to 70 of about 172,356 (250)

Streptococcus pyogenes adhesion and colonization [PDF]

open access: yesFEBS Letters, 2016
Streptococcus pyogenes (group A Streptococcus, GAS) is a human‐adapted pathogen responsible for a wide spectrum of disease. GAS can cause relatively mild illnesses, such as strep throat or impetigo, and less frequent but severe life‐threatening diseases such as necrotizing fasciitis and streptococcal toxic shock syndrome.
Brouwer, Stephan   +4 more
openaire   +6 more sources

Role of glucose and CcpA in capsule expression and virulence of Streptococcus suis [PDF]

open access: yes, 2011
Streptococcus suis is one of the most important pathogens in pigs and is also an emerging zoonotic agent. After crossing the epithelial barrier, S. suis causes bacteraemia, resulting in meningitis, endocarditis and bronchopneumonia.
Smith, H.E.   +20 more
core   +1 more source

THE STREPTOCOCCUS PYOGENES IN GYNECOLOGICAL DISEASES. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1901
In 1899 I reported 7 cases 1 of pelvic inflammation operated on in the gynecological clinic of the Johns Hopkins Hospital, in which the streptococcus pyogenes was found to be the infecting agent. Since the publication of that article, and during my service in the hospital, 4 additional cases have been operated on in which this micro-organism was found ...
openaire   +1 more source

Enhanced CRISPR‐cas systems for genome editing and molecular diagnostics

open access: yesInterdisciplinary Medicine, EarlyView.
This review systematically summarizes the major optimization strategies for CRISPR‐Cas systems, focusing on the engineering of Cas proteins, guide RNAs, reporter probes, and the incorporation of chemical additives. The aim is to enhance editing precision and diagnostic capability, thereby expanding the CRISPR system's potential for broader biomedical ...
Sheng Li   +7 more
wiley   +1 more source

Emergence of a new highly successful acapsular Group A Streptococcus clade of the genotype emm89 in the United Kingdom [PDF]

open access: yes, 2015
This work was supported by the National Institute for Health Research Biomedical Research Centre awarded to Imperial College Healthcare Trust, and the UK Clinical Research Collaboration (National Centre for Infection Prevention & Management).Group A ...
Abbott, James   +38 more
core   +1 more source

Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius

open access: yesInternational Journal of Microbiology, 2012
Salivaricin G32, a 2667 Da novel member of the SA-FF22 cluster of lantibiotics, has been purified and characterized from Streptococcus salivarius strain G32.
Philip A. Wescombe   +8 more
doaj   +1 more source

Streptococcus pyogenes-purpura fulminans as an invasive form of group A streptococcal infection

open access: yesAnnals of Clinical Microbiology and Antimicrobials, 2018
Background Streptococcus pyogenes is an uncommon pathogen of purpura fulminans, and the pathogenesis of S. pyogenes-purpura fulminans remains unclear because of paucity of cases. We reported a pediatric case of S.
Sayaka Okuzono   +13 more
doaj   +1 more source

Erythromycin-resistant Streptococcus pyogenes

open access: yesSrpski arhiv za celokupno lekarstvo, 2004
Streptococcus pyogenes is the most prevalent cause of tonsillopharyngitis in children. The drug of choice for infections caused by this microorganism is penicillin. The problem of treating such infections arises when erythromycin-resistant strains occur.
Gordana, Lazarević   +3 more
openaire   +2 more sources

Diverse Uses of Lantibiotics: Exploring New Approaches to Combat Antibiotic Resistance

open access: yesMedicine Advances, EarlyView.
This review illustrates lantibiotics as an alternative therapeutic approach to combat antibiotic resistance, highlighting their diverse sources, including plants, insects, animals, and microorganisms. It further emphasizes their broad therapeutic potential, including antibacterial, antifungal, antiparasitic, antiviral, and anticancer activities (GA ...
Gopalarethinam Janani   +5 more
wiley   +1 more source

Streptococcus pyogenes strains used in this study.

open access: yes, 2014
Streptococcus pyogenes strains used in this study.
Jeffrey A. Mayfield (589111)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy